6505--Ipsen Biopharmaceuticals, Inc., dba Tercica, Inc. 65IB 36F79726D0137 Effective: 06/01/2026-05/31/2031 36F79726D0137
Summary
AI-generated · May 29, 2026A contract has been awarded to Ipsen Biopharmaceuticals, Inc., doing business as Tercica, Inc., for $760,715,800. The award was issued on May 28, 2026, with a performance period from June 1, 2026, to May 31, 2031.
The notice does not include a description of the required work, scope, or any special terms. No additional procurement or bidding details are provided in the notice.
Notice history
1Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| IPSEN BIOPHARMACEUTICALS INC | YJTQU9382HU5 | 4DX58 | CAMBRIDGE |
Contacts
VA Federal Supply Schedule (FSS) Service
Phone